Search All News
Columbia Psychiatry is among the principal investigators in biotech Compass Pathways study of more than 200 patients.
This year’s Eric D. Hadar Lecture will take place on November 3, 2021 with Dr. Steven Shoptaw, who will present, “Medications as Foundation for Stimulant Use Disorder Treatment: Is it Time?”
- September 21, 2021
Columbia Psychiatry's Caroline Arout uses quantitative sensory testing, or QST, for assessing the effectiveness of cannabis for therapeutic uses.
- September 15, 2021
Dr. Sidney Hankerson is one of 10 scholars named as 2021’s Emerging Leaders in Health and Medicine by the National Academy of Medicine (NAM).
- September 13, 2021
Ravi N. Shah, MD has been named Chief Innovation Officer for Columbia Psychiatry.
- August 10, 2021
A collaborative study from Columbia University and the Copenhagen Research Centre for Mental Health examines the relationship between Lyme disease and psychiatric outcomes.
Source:U.S. NewsJuly 19, 2021
Dr. Joshua Berman said electrical stimulation (ECT) seems to trigger the release of "neurotrophic" factors, which can help brain cells grow.
Source:NBC NewsJuly 16, 2021
“Our study provides further evidence that marijuana use is not effective in reducing nonmedical opioid use,” said study author Dr. Mark Olfson.
Source:TIMEJuly 13, 2021
“The biggest limiting factor in getting to remission from depression postpartum is access to care, period—and it is worse for people who don’t have financial resources,” says Dr. Catherine Monk.